Authors:
Weis, S
King, B
Thompson, SF
Shaffer, N
Jones, B
Puentes, S
Silva, C
Hershfield, E
Izon, G
Mangura, B
Reichman, L
Leus, MC
Owens, M
Lahart, C
Nickson, R
Scott, T
Awe, R
Murphy, AL
Weiner, M
Engle, M
Chaisson, R
Sterling, T
Hackman, J
Wilcox, F
Wassler, P
Dukes-Hamilton, C
Mosher, A
Ho, B
Reves, R
Burman, W
Peloquin, C
Tapy, J
Rom, W
Condos, R
Sandman, L
Bhattacharya, M
Fabre, J
El-Sadr, W
Klein, M
Horton, J
Quinn, E
Pachuki, C
Samuel, M
Gordin, F
Benator, D
Sepulveda, D
Quinlan-Mauzy, C
Kernodle, D
McKee, GS
Reeves-Hammock, L
Bernardo, J
Horsburgh, CR
Saukkonen, J
Murphy, C
Schluger, N
Burzynski, J
Lozano, V
Menzies, R
Schwartzman, K
Pelletier, M
Valiquette, C
Nolan, C
Goldberg, S
Stone, M
Fitzgerald, M
Hernandez, E
Peyvandi, B
Daley, C
Hopewell, P
Stanton, B
Merrifield, C
Donovan, C
Hobbs, B
Gotting, V
Therrien, M
Ferrell, S
Bozeman, L
Broadnax, S
Carter, C
Dansbury, K
Gross, L
Henderson, C
Jackson, M
Khan, A
O'Brien, R
Sharma, A
Villarino, ME
Wang, YC
Cooksey, R
Crawford, J
Sikes, D
Metchock, B
Sheppard, J
Woodley, C
Jaffe, H
Neaton, J
Bass, J
Citation: S. Weis et al., The tuberculosis trials consortium: A model for clinical trials collaborations, PUBL HEA RE, 116, 2001, pp. 41-49
Authors:
Gordin, F
Chaisson, RE
Matts, JP
Miller, C
Garcia, MD
Hafner, R
Valdespino, JL
Coberly, J
Schechter, M
Klukowicz, AJ
Barry, MA
O'Brien, RJ
Citation: F. Gordin et al., Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons - An international randomized trial, J AM MED A, 283(11), 2000, pp. 1445-1450
Authors:
El-Sadr, WM
Burman, WJ
Grant, LB
Matts, JP
Hafner, R
Crane, L
Zeh, D
Gallagher, B
Mannheimer, SB
Martinez, A
Gordin, F
Citation: Wm. El-sadr et al., Discontinuation of prophylaxis against Mycobacterium avium complex diseasein HIV-infected patients who have a response to antiretroviral therapy., N ENG J MED, 342(15), 2000, pp. 1085-1092
Authors:
Birx, DL
Loomis-Price, LD
Aronson, N
Brundage, J
Davis, C
Deyton, L
Garner, R
Gordin, F
Henry, D
Holloway, W
Kerkering, T
Luskin-Hawk, R
McNeil, J
Michael, N
Pierce, PF
Poretz, D
Ratto-Kim, S
Renzullo, P
Ruiz, N
Sitz, K
Smith, G
Tacket, C
Thompson, M
Tramont, E
Yangco, B
Yarrish, R
Redfield, RR
Citation: Dl. Birx et al., Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers, J INFEC DIS, 181(3), 2000, pp. 881-889